BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23326516)

  • 1. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
    Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
    PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
    Maselli RA; Arredondo J; Cagney O; Ng JJ; Anderson JA; Williams C; Gerke BJ; Soliven B; Wollmann RL
    Hum Mol Genet; 2010 Jun; 19(12):2370-9. PubMed ID: 20371544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    J Soc Biol; 2005; 199(1):61-77. PubMed ID: 16114265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
    Yamanashi Y; Higuch O; Beeson D
    Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
    Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
    Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUSK, a new target for mutations causing congenital myasthenic syndrome.
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    Hum Mol Genet; 2004 Dec; 13(24):3229-40. PubMed ID: 15496425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
    Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
    Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.
    Huzé C; Bauché S; Richard P; Chevessier F; Goillot E; Gaudon K; Ben Ammar A; Chaboud A; Grosjean I; Lecuyer HA; Bernard V; Rouche A; Alexandri N; Kuntzer T; Fardeau M; Fournier E; Brancaccio A; Rüegg MA; Koenig J; Eymard B; Schaeffer L; Hantaï D
    Am J Hum Genet; 2009 Aug; 85(2):155-67. PubMed ID: 19631309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.
    Maselli RA; Fernandez JM; Arredondo J; Navarro C; Ngo M; Beeson D; Cagney O; Williams DC; Wollmann RL; Yarov-Yarovoy V; Ferns MJ
    Hum Genet; 2012 Jul; 131(7):1123-35. PubMed ID: 22205389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation.
    Hubbard SR; Gnanasambandan K
    Biochim Biophys Acta; 2013 Oct; 1834(10):2166-9. PubMed ID: 23467009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
    Okada K; Inoue A; Okada M; Murata Y; Kakuta S; Jigami T; Kubo S; Shiraishi H; Eguchi K; Motomura M; Akiyama T; Iwakura Y; Higuchi O; Yamanashi Y
    Science; 2006 Jun; 312(5781):1802-5. PubMed ID: 16794080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSk function during health and disease.
    Herbst R
    Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.
    Hallock PT; Xu CF; Park TJ; Neubert TA; Curran T; Burden SJ
    Genes Dev; 2010 Nov; 24(21):2451-61. PubMed ID: 21041412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.
    Rodríguez Cruz PM; Cossins J; Cheung J; Maxwell S; Jayawant S; Herbst R; Waithe D; Kornev AP; Palace J; Beeson D
    Hum Mutat; 2020 Mar; 41(3):619-631. PubMed ID: 31765060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
    Hamuro J; Higuchi O; Okada K; Ueno M; Iemura S; Natsume T; Spearman H; Beeson D; Yamanashi Y
    J Biol Chem; 2008 Feb; 283(9):5518-24. PubMed ID: 18165682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
    Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
    Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia.
    Selcen D; Ohkawara B; Shen XM; McEvoy K; Ohno K; Engel AG
    JAMA Neurol; 2015 Aug; 72(8):889-96. PubMed ID: 26052878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance.
    Messéant J; Dobbertin A; Girard E; Delers P; Manuel M; Mangione F; Schmitt A; Le Denmat D; Molgó J; Zytnicki D; Schaeffer L; Legay C; Strochlic L
    J Neurosci; 2015 Mar; 35(12):4926-41. PubMed ID: 25810523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental consequences of the ColQ/MuSK interactions.
    Karmouch J; Dobbertin A; Sigoillot S; Legay C
    Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.